美国退伍军人事务部医疗系统中膀胱癌诊断分期的种族差异
该回顾性队列研究纳入2000至2020年美国退伍军人事务部医疗系统中15966例确诊膀胱癌的男性,按种族分析诊断时的病理分期。黑人患者初诊肌层浸润性膀胱癌比例高于白人患者(35% vs 32%,P=0.009),但多因素分析中黑人(OR 1.10,95%CI 0.98-1.22)与西班牙裔(OR 0.82,95%CI 0.67-1.01)和白人相比无显著差异;黑人膀胱癌特异性死亡风险与白人相似(HR 0.89,95%CI 0.75-1.06),西班牙裔则较低(HR 0.56,95%CI 0.38-0.82)。
要点
- 黑人膀胱癌患者初诊肌层浸润性比例高于白人(35% vs 32%,P=0.009)。
- 多因素分析中黑人(OR 1.10,95%CI 0.98-1.22)与西班牙裔(OR 0.82,95%CI 0.67-1.01)肌层浸润风险与白人无显著差异。
- 黑人膀胱癌特异性死亡风险与白人相似(HR 0.89,95%CI 0.75-1.06),西班牙裔较低(HR 0.56,95%CI 0.38-0.82)。
核心结论
- 黑人膀胱癌患者初诊肌层浸润性比例最高(35% vs 白人32%,P=0.009),但在大型平等可及医疗系统中未导致膀胱癌特异性死亡率差异(黑人HR 0.89,95%CI 0.75-1.06)。
- 西班牙裔患者肌层浸润风险(OR 0.82,95%CI 0.67-1.01)和膀胱癌特异性死亡风险(HR 0.56,95%CI 0.38-0.82)均较低。
研究设计与样本
- 回顾性队列研究,纳入2000至2020年美国退伍军人事务部医疗系统中15966例确诊膀胱癌的男性。
- 主要结局为经索引经尿道膀胱肿瘤电切术确定的诊断时病理分期,采用逻辑回归分析种族与分期的关系,竞争风险模型检验种族与膀胱癌特异性死亡的相关性并估算累积发生率。
主要发现
- 15966例中白人12868例(81%)、黑人1726例(11%)、西班牙裔493例(3%)、其他种族879例(6%)。
- 黑人患者肌层浸润性膀胱癌比例显著高于白人患者(35% vs 32%,P=0.009)。
- 多因素分析中黑人(OR 1.10,95%CI 0.98-1.22)和西班牙裔(OR 0.82,95%CI 0.67-1.01)与白人相比肌层浸润风险无显著差异。
- 黑人膀胱癌特异性死亡风险与白人相似(HR 0.89,95%CI 0.75-1.06),西班牙裔较低(HR 0.56,95%CI 0.38-0.82)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe patient characteristics and pathological stage at bladder cancer (BCa) diagnosis in a diverse population within a national, equal-access healthcare system. METHODS: This retrospective cohort study identified 15 966 men diagnosed with BCa in the Veterans Affairs (VA) healthcare system from 2000 to 2020. The primary outcome was pathological stage at diagnosis, determined by index transurethral resection of bladder tumour. Logistic regression was used to assess the relationship between race and stage. Competing risk models tested the association between race and BCa-specific mortality with cumulative incidence estimates. RESULTS: Of 15 966 BCa patients, 12 868 (81%), 1726 (11%), 493 (3%) and 879 (6%) were White, Black, Hispanic and Other race, respectively. Black patients had significantly higher muscle-invasive bladder cancer (MIBC) rates than White patients (35% vs 32%; P = 0.009). In multivariable analysis, the odds of presenting with MIBC did not differ significantly between Black and White patients (odds ratio [OR] 1.10, 95% confidence interval [CI] 0.98-1.22) or between Hispanic patients (OR 0.82, 95% CI 0.67-1.01) and White patients. Compared to White patients, Black patients had a similar risk of BCa-specific mortality (hazard ratio [HR] 0.89, 95% CI 0.75-1.06), whereas Hispanic patients had a lower risk (HR 0.56, 95% CI 0.38-0.82). CONCLUSIONS: Black patients presented with the highest rates of de novo MIBC. However, in a large, equal-access healthcare system, this did not result in a difference in BCa-specific mortality. In contrast, Hispanic patients had lower risks of MIBC and BCa-specific mortality.
引用
- Bree KK, Janes JL, Hensley PJ, et al. Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system. BJU Int. 2024. PMID: 38680113. doi:10.1111/bju.16380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。